Cargando…
Iron Deficiency and Blood Donation: Links, Risks and Management
The purpose of this review is to raise awareness about the frequently underappreciated association of blood donation with iron deficiency, and to describe methods for its prevention and management. Blood donors cannot expect any health benefits from the donation but have justified expectations of no...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749410/ https://www.ncbi.nlm.nih.gov/pubmed/36531435 http://dx.doi.org/10.2147/JBM.S375945 |
_version_ | 1784850036785414144 |
---|---|
author | Mantadakis, Elpis Panagopoulou, Paraskevi Kontekaki, Eftychia Bezirgiannidou, Zoe Martinis, Georges |
author_facet | Mantadakis, Elpis Panagopoulou, Paraskevi Kontekaki, Eftychia Bezirgiannidou, Zoe Martinis, Georges |
author_sort | Mantadakis, Elpis |
collection | PubMed |
description | The purpose of this review is to raise awareness about the frequently underappreciated association of blood donation with iron deficiency, and to describe methods for its prevention and management. Blood donors cannot expect any health benefits from the donation but have justified expectations of no harm. Iron deficiency without anemia (IDWA) and iron deficiency anemia (IDA) are common consequences of regular blood donation, and this activity is the most important factor affecting iron status in regular blood donors. Awareness of blood donation as a primary cause of sideropenia is surprisingly low among physicians. Blood donation screening identifies potential donors with IDA but is frequently inadequate to detect IDWA. For the assessment of body iron stores, plasma or serum ferritin, transferrin saturation (TSAT) and soluble transferrin receptors (sTfR) concentrations are the most widely used biochemical markers, although the percentage of hypochromic mature erythrocytes and the hemoglobin content of reticulocytes are also useful. IDWA can be prevented by limiting the total volume of blood collected, by iron deficiency screening and deferral of sideropenic donors, by prolonging the interdonation intervals, and by iron supplementation between donations. IDWA tends to be more prevalent in younger people, females, and high-intensity donors. A potentially effective strategy to address sideropenia in blood donors is serum ferritin testing, but this may lead to a higher rate of deferral. Most regular blood donors cannot replenish their iron deficit by an iron-rich diet alone and will benefit from low-dose oral iron administration with various commercially available products post-donation, a well-tolerated strategy. However, valid concerns exist regarding the possibility of worsening the iron overload in donors with undiagnosed hemochromatosis or masking the symptoms of a clinically important gastrointestinal hemorrhage or other underlying medical condition. Finally, educational efforts should be intensified to improve the awareness of blood donation as a primary cause of iron deficiency among physicians of all specialties. |
format | Online Article Text |
id | pubmed-9749410 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-97494102022-12-15 Iron Deficiency and Blood Donation: Links, Risks and Management Mantadakis, Elpis Panagopoulou, Paraskevi Kontekaki, Eftychia Bezirgiannidou, Zoe Martinis, Georges J Blood Med Review The purpose of this review is to raise awareness about the frequently underappreciated association of blood donation with iron deficiency, and to describe methods for its prevention and management. Blood donors cannot expect any health benefits from the donation but have justified expectations of no harm. Iron deficiency without anemia (IDWA) and iron deficiency anemia (IDA) are common consequences of regular blood donation, and this activity is the most important factor affecting iron status in regular blood donors. Awareness of blood donation as a primary cause of sideropenia is surprisingly low among physicians. Blood donation screening identifies potential donors with IDA but is frequently inadequate to detect IDWA. For the assessment of body iron stores, plasma or serum ferritin, transferrin saturation (TSAT) and soluble transferrin receptors (sTfR) concentrations are the most widely used biochemical markers, although the percentage of hypochromic mature erythrocytes and the hemoglobin content of reticulocytes are also useful. IDWA can be prevented by limiting the total volume of blood collected, by iron deficiency screening and deferral of sideropenic donors, by prolonging the interdonation intervals, and by iron supplementation between donations. IDWA tends to be more prevalent in younger people, females, and high-intensity donors. A potentially effective strategy to address sideropenia in blood donors is serum ferritin testing, but this may lead to a higher rate of deferral. Most regular blood donors cannot replenish their iron deficit by an iron-rich diet alone and will benefit from low-dose oral iron administration with various commercially available products post-donation, a well-tolerated strategy. However, valid concerns exist regarding the possibility of worsening the iron overload in donors with undiagnosed hemochromatosis or masking the symptoms of a clinically important gastrointestinal hemorrhage or other underlying medical condition. Finally, educational efforts should be intensified to improve the awareness of blood donation as a primary cause of iron deficiency among physicians of all specialties. Dove 2022-12-10 /pmc/articles/PMC9749410/ /pubmed/36531435 http://dx.doi.org/10.2147/JBM.S375945 Text en © 2022 Mantadakis et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Mantadakis, Elpis Panagopoulou, Paraskevi Kontekaki, Eftychia Bezirgiannidou, Zoe Martinis, Georges Iron Deficiency and Blood Donation: Links, Risks and Management |
title | Iron Deficiency and Blood Donation: Links, Risks and Management |
title_full | Iron Deficiency and Blood Donation: Links, Risks and Management |
title_fullStr | Iron Deficiency and Blood Donation: Links, Risks and Management |
title_full_unstemmed | Iron Deficiency and Blood Donation: Links, Risks and Management |
title_short | Iron Deficiency and Blood Donation: Links, Risks and Management |
title_sort | iron deficiency and blood donation: links, risks and management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749410/ https://www.ncbi.nlm.nih.gov/pubmed/36531435 http://dx.doi.org/10.2147/JBM.S375945 |
work_keys_str_mv | AT mantadakiselpis irondeficiencyandblooddonationlinksrisksandmanagement AT panagopoulouparaskevi irondeficiencyandblooddonationlinksrisksandmanagement AT kontekakieftychia irondeficiencyandblooddonationlinksrisksandmanagement AT bezirgiannidouzoe irondeficiencyandblooddonationlinksrisksandmanagement AT martinisgeorges irondeficiencyandblooddonationlinksrisksandmanagement |